Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
InVitria
Fort Collins, Colorado, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
InVitria provides recombinant, animal-component-free cell culture media supplements and reagents that have supported over 300 customer clinical programs globally; these products are used for improved performance, consistency, and safety in research, development, and commercial manufacture of biologics, cell and gene therapies, and vaccines
- Therapeutic areas
- HematologyInfectious DiseasesOther
- Modalities
- Recombinant proteinRecombinant fusion proteinBiologic
- Industry
- Chemicals & Materials
02
Partnerships
Not explicitly listed; primary customers are biopharma and cell/gene therapy firmsVentria Bioscience (the parent) has received support from the Bill & Melinda Gates Foundation
Beyond the preview
Go deeper on InVitria.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on InVitria.